Echo Street Capital Management Raised Its Grace W R & Co Del New (GRA) Position; 5 Analysts Covering CymaBay Therapeutics (CBAY)

September 17, 2017 - By Vivian Currie

Among 5 analysts covering Cymabay Therapeutics Inc (NASDAQ:CBAY), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cymabay Therapeutics Inc had 13 analyst reports since July 21, 2015 according to SRatingsIntel. As per Tuesday, July 21, the company rating was initiated by Piper Jaffray. H.C. Wainwright downgraded CymaBay Therapeutics Inc (NASDAQ:CBAY) rating on Wednesday, June 1. H.C. Wainwright has “Neutral” rating and $2.25 target. H.C. Wainwright maintained the stock with “Buy” rating in Wednesday, March 30 report. The company was maintained on Wednesday, January 4 by H.C. Wainwright. The company was maintained on Tuesday, July 25 by Piper Jaffray. On Friday, July 1 the stock rating was initiated by Roth Capital with “Buy”. The stock of CymaBay Therapeutics Inc (NASDAQ:CBAY) has “Buy” rating given on Monday, July 17 by H.C. Wainwright. H.C. Wainwright initiated it with “Buy” rating and $12 target in Tuesday, September 8 report. The company was maintained on Monday, September 11 by Piper Jaffray. The company was maintained on Monday, July 17 by Piper Jaffray. See CymaBay Therapeutics Inc (NASDAQ:CBAY) latest ratings:

11/09/2017 Broker: Piper Jaffray Rating: Buy New Target: $12.0 Maintain
23/08/2017 Broker: Leerink Swann Rating: Outperform New Target: $12 Initiates Coverage On
25/07/2017 Broker: Piper Jaffray Rating: Buy New Target: $12.0000 Maintain
17/07/2017 Broker: Piper Jaffray Rating: Buy New Target: $6.5000 Maintain
17/07/2017 Broker: H.C. Wainwright Rating: Buy New Target: $12.0000 Maintain
23/06/2017 Broker: Oppenheimer Rating: Outperform New Target: $8 Initiates Coverage On

Echo Street Capital Management Llc increased Grace W R & Co Del New (GRA) stake by 60.22% reported in 2016Q4 SEC filing. Echo Street Capital Management Llc acquired 128,434 shares as Grace W R & Co Del New (GRA)’s stock declined 0.67%. The Echo Street Capital Management Llc holds 341,693 shares with $23.11M value, up from 213,259 last quarter. Grace W R & Co Del New now has $4.97B valuation. The stock increased 0.47% or $0.34 on September 15, reaching $72.79. About 959,564 shares traded or 70.05% up from the average. W. R. Grace & Co (NYSE:GRA) has declined 6.22% since September 17, 2016 and is downtrending. It has underperformed by 22.92% the S&P500.

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $315.05 million. The Firm is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. It currently has negative earnings. The Company’s product candidates include Arhalofenate, MBX-8025 and MBX-2982.

The stock increased 2.27% or $0.16 on September 15, reaching $7.2. About 738,984 shares traded or 9.20% up from the average. CymaBay Therapeutics Inc (NASDAQ:CBAY) has risen 69.26% since September 17, 2016 and is uptrending. It has outperformed by 52.56% the S&P500.

Among 12 analysts covering W. R. Grace & Co (NYSE:GRA), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. W. R. Grace & Co had 21 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Outperform” rating by Macquarie Research given on Monday, March 7. Jefferies maintained W. R. Grace & Co (NYSE:GRA) on Wednesday, July 19 with “Hold” rating. The stock of W. R. Grace & Co (NYSE:GRA) has “Buy” rating given on Monday, December 12 by Goldman Sachs. The stock of W. R. Grace & Co (NYSE:GRA) earned “Hold” rating by BB&T Capital on Thursday, December 10. As per Monday, August 3, the company rating was downgraded by Tigress Financial. Jefferies maintained it with “Hold” rating and $70.0 target in Thursday, August 31 report. Goldman Sachs downgraded it to “Buy” rating and $103 target in Wednesday, January 27 report. The stock of W. R. Grace & Co (NYSE:GRA) has “Buy” rating given on Friday, September 1 by KeyBanc Capital Markets. The firm has “Buy” rating given on Tuesday, November 1 by Seaport Global Securities. Robert W. Baird upgraded it to “Outperform” rating and $85 target in Tuesday, February 7 report.

Echo Street Capital Management Llc decreased Ppg Inds Inc (NYSE:PPG) stake by 69,751 shares to 61,410 valued at $5.82M in 2016Q4. It also reduced Life Storage Inc stake by 82,983 shares and now owns 210,479 shares. Mgm Growth Pptys Llc was reduced too.

Investors sentiment decreased to 0.71 in 2016 Q4. Its down 0.50, from 1.21 in 2016Q3. It dived, as 46 investors sold GRA shares while 91 reduced holdings. 36 funds opened positions while 84 raised stakes. 56.49 million shares or 1.59% less from 57.40 million shares in 2016Q3 were reported. Hudock Grp Inc Ltd Liability Com invested in 0.04% or 971 shares. Atlantic Grp Ltd Liability holds 15,473 shares. Cullinan Assocs owns 6,600 shares. Macquarie Group invested 0.02% in W. R. Grace & Co (NYSE:GRA). Timber Hill Ltd Liability has invested 0.01% of its portfolio in W. R. Grace & Co (NYSE:GRA). Royal Comml Bank Of Canada, Ontario – Canada-based fund reported 3,191 shares. Princeton Alpha Mngmt Ltd Partnership holds 8,795 shares. First Manhattan holds 640,747 shares. Us Bancshares De, a Minnesota-based fund reported 2,130 shares. Blackrock Institutional Trust Na has 1.91M shares for 0.02% of their portfolio. Moreover, Blackrock Mngmt Ltd Company has 0% invested in W. R. Grace & Co (NYSE:GRA). Axa has invested 0.02% of its portfolio in W. R. Grace & Co (NYSE:GRA). Manchester Capital Management Limited Com invested in 3,502 shares. Citigroup invested in 152,456 shares or 0.01% of the stock. Lorber David A invested 3.46% in W. R. Grace & Co (NYSE:GRA).

Since May 16, 2017, it had 0 insider buys, and 2 sales for $2.26 million activity. Dockman William C. sold $345,919 worth of stock or 4,940 shares. $1.92 million worth of W. R. Grace & Co (NYSE:GRA) was sold by Shelnitz Mark A on Wednesday, June 14.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com